New eye drug shows promise for diabetic vision loss
Disease control
Completed
This study tested a drug called faricimab in 179 people with non-proliferative diabetic retinopathy, a condition where diabetes damages blood vessels in the eye. The goal was to see if the drug could improve blood flow in the retina over 48 weeks. Participants received either mon…
Phase: PHASE2 • Sponsor: Greater Houston Retina Research • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC